Adamantinoma
Aftercare
Neoplasm Metastasis

Adamantinoma

Adamantinomas are rare, low-grade malignant bone tumors primarily observed in individuals aged 20 to 40. Adamantinomas have a mortality rate of 6% to 18% and a metastasis frequency of 12% to 29% due to their local aggressiveness and metastatic potential. Timely diagnosis and treatment are crucial in mitigating this condition’s associated morbidity and mortality risks. The unpredictable behavior of adamantinomas, including late recurrences after surgical excision, underscores the necessity for long-term, vigilant follow-up care. This activity elucidates the clinical characteristics, diagnostic evaluation, and treatment options for adamantinomas, emphasizing the importance of collaboration among healthcare professionals. This activity also aims to enhance the clinical competency of interprofessional healthcare team members, including orthopedic surgeons, oncologists, radiologists, pathologists, and nurses involved in caring for patients with adamantinomas. Upon completing the activity, participants can identify clinical presentations, apply suitable diagnostic techniques, assess treatment choices, and understand the significance of sustained follow-up care and interprofessional teamwork.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.